[S100A4, a link between metastasis and inflammation]

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Chronic inflammation is a key factor in cancer development and spread.
• The S100A4 protein, a calcium-binding protein, is known to promote tumor metastasis.
• S100A4 is also linked to the pathogenesis of non-communicable diseases (NCDs) like autoimmune disorders and fibrosis.

Purpose of the Study:

• To summarize evidence suggesting S100A4 acts as a trigger for inflammatory processes in cancer.
• To highlight the role of S100A4 in promoting primary tumor growth and metastatic dissemination.
• To propose S100A4 as a common pro-inflammatory factor in diverse NCDs, including cancer.

Main Methods:

• Literature review and data summarization.
• Analysis of S100A4's function within the S100 superfamily.
• Examination of S100A4's involvement in both neoplastic and non-communicable diseases.

Main Results:

• Data suggests S100A4 initiates inflammatory cascades that foster a tumor-promoting environment.
• S100A4 significantly contributes to primary tumor growth and enhances metastatic spread.
• The protein's role extends beyond cancer to other inflammatory NCDs.

Conclusions:

• S100A4 is identified as a critical initiator of inflammation in cancer progression and metastasis.
• S100A4's involvement in various NCDs points to its broader role as a common pro-inflammatory mediator.
• Targeting S100A4 may offer therapeutic potential for both cancer and other inflammatory conditions.